Is Mounjaro Worth It for Weight Loss?

Dual-pathway mechanism: Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors, the only licensed weight-loss medicine in the UK to do so — reducing appetite and slowing gastric emptying through two complementary routes.
Trial-backed results: In the SURMOUNT-1 study (2,539 adults, 72 weeks), participants on 15 mg lost an average of around 20–21% of body weight, more than any other licensed injectable in head-to-head evidence.
Side effects are real but manageable: Most people experience some GI symptoms early on (nausea, loose stools, indigestion) which typically ease within a couple of weeks of each dose step.
Private prescription route: Mounjaro is available privately without the NHS waiting list, subject to clinical assessment by a GPhC-registered prescriber.

For most adults who meet the clinical criteria, Mounjaro delivers meaningful, sustained weight loss that other methods haven't matched — clinical trials recorded average body-weight reductions of around 20% at the highest dose over 72 weeks. That said, whether Mounjaro is worth it for you depends on your health picture, your expectations and the quality of support around your treatment. It is a prescription-only medicine, so a prescriber assesses whether it is clinically appropriate before anything is dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A practical framework for deciding whether Mounjaro is worth the investment

Step 1: Look honestly at what the evidence shows

The starting point for any 'is it worth it' question is what tirzepatide actually does in controlled conditions. The SURMOUNT-1 trial (published in the New England Journal of Medicine) followed 2,539 adults with obesity over 72 weeks. Those on the 15 mg dose lost an average of roughly 20–21% of their starting body weight. That is a substantial figure by any clinical benchmark. Head-to-head data from SURMOUNT-5 (2025) showed tirzepatide producing greater average weight reduction than semaglutide 2.4 mg over the same period.

These are averages. Some people lose more; some less. The trial participants also followed a reduced-calorie diet and increased their activity, which matters when you are setting your own expectations. Mounjaro reduces appetite markedly for most people, which makes those lifestyle changes considerably easier to sustain, but the medicine works alongside them, not instead of them. You can read the background on what Mounjaro is and how it works if you want the mechanism before the numbers.

One thing the evidence does not show: results that stick permanently after you stop. Weight management is a long-term conversation between you, the medicine and a prescriber who knows your case.

Step 2: Weigh the costs against what is actually included

Private Mounjaro costs vary by dose and provider. Since Eli Lilly adjusted UK list pricing in September 2025, the market for higher doses typically sits anywhere from roughly £149 to £375 per month depending on strength and where you get it, figures that have been widely reported. On our Mounjaro treatment page you can see current pricing for each dose.

The question worth asking is not 'what is the lowest number I can find online' but 'what does that number actually include?' Some headline prices strip out the prescription fee, the clinical consultation, delivery and any follow-up support. A transparent price that covers all of those is a better comparison than a bare pen price that does not. For a fuller breakdown of what drives private treatment costs, the weight-loss treatments overview sets out what a complete private service looks like.

Timing matters in practice too. Orders placed before 12pm on a weekday go out the same day once approved, so if you are thinking about starting around payday or want treatment in hand before a busy period, that window is worth planning around.

Step 3: Assess your personal health picture honestly

Mounjaro is licensed in the UK for adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present, such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone, though, is not the whole picture. A prescriber also looks at your medical history, current medications and whether any contraindications apply.

There are situations where tirzepatide is not appropriate: pregnancy, breastfeeding, or actively trying to conceive; under-18s; a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. People using oral contraceptives need to know that absorption of the pill can be reduced during the first four weeks of treatment and after each dose increase, so a backup contraceptive method is recommended during those windows. If you are also prescribed a stimulant medication, our page on taking Mounjaro alongside Elvanse covers what you need to know about using both together. The tirzepatide overview covers these safety considerations in more detail.

Side effects are worth factoring in honestly. Nausea, loose stools and indigestion are common, especially after starting or moving up a dose. They are not usually severe, and for most people they settle. The NHS tirzepatide medicines page lists the full side-effect profile with guidance on when to seek help. A question our prescribers hear regularly: 'Will I feel awful for weeks?' The honest answer is that many people feel some GI discomfort in the first week or two, then find it manageable.

Step 4: Think about what 'worth it' actually means to you

Clinical efficacy and cost are two legs of the decision. The third is your own definition of success. For some people, the value is a 10–15% weight reduction that brings blood pressure or blood sugar into a healthier range. For others, it is reaching a BMI that opens up surgical or fertility options. Both are legitimate.

What Mounjaro is not: a short course with permanent results, or a medicine that works without any lifestyle engagement. The people who get the most from it tend to use the appetite suppression it creates to build genuinely different eating habits, not just eat less of the same things. If you want to understand how Mounjaro is taken week to week, including injection technique and timing, that is worth reading before you start. If you have come across the name tirzepatide and are unsure whether tirzepatide and Mounjaro are the same thing, that page explains the relationship clearly. And if you are exploring how tirzepatide fits into the broader range of weight-loss options, comparing the full picture makes sense before committing.

A realistic framing: for people who meet the clinical criteria and approach it with the right expectations, the evidence consistently supports Mounjaro as the most effective weight-loss medicine currently licensed in the UK. Whether that makes it worth it is a question that belongs in a consultation, with a prescriber who can apply that evidence to your specific situation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions